Thierry Cournez

Thierry Cournez joined Oxford Biomedica as Chief Operating Officer in October 2023. Mr Cournez has extensive experience in Sales, Marketing and GMP/GLP operations, with broad industry knowledge in the life science, biopharma and CDMO ecosystems. Prior to joining Oxford Biomedica, Mr Cournez served as Vice President of Global Testing Operations Bioreliance® at Merck Life Science, where he successfully managed large capacity expansion projects and held international responsibility for contract testing operations across the US, UK, Singapore and China. Prior to this, in his role as Vice President of End-to-End Bioprocessing Solutions, Mr Cournez built and developed Merck Life Science’s End-to-End Promise Venture business unit, which involved the delivery and implementation of CDMO solutions for biopharma clients. Mr Cournez holds an Engineer’s Degree in Biochemistry and Molecular Biology from INSA, Lyon, alongside a Master’s of Science in Molecular Biology from Paris VI University.